By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
Managing Partner at Generation Capital Partners and Founder and Principal of Whipstick Ventures LLC
Jeffrey serves as a managing partner of Whipstick Ventures and Generation Capital, and was the Chief Financial Officer and Vice Chairman of General Electric until October 2017. Previously, Mr. Bornstein served as a Senior Vice President and Chief Financial Officer of GE Capital. He is a trustee of Northeastern University, and a member of the Board of Directors of buildOn, Inc. Mr. Bornstein obtained his BS degree from Northeastern University.
Life @ AlloVir
Mission-driven teams developing transformative cell therapies for patients deserve transformative benefits. We make sure your life outside the lab is as purposeful as your life inside it.
Life @AlloVir
Trust, commitment, and the drive to build something together. Interested in being part of our vision? Check out our open positions.
Making sure that you have the freedom to time off when you need to is an important part of our culture. Life beyond the lab includes a flexible approach to PTO; you take it when you need it.
Life @AlloVir
Trust, commitment, and the drive to build something together. Interested in being part of our vision? Check out our open positions.
Being connected and getting where you need to go is an important part of your work. We offer cell phone and commuter reimbursement programs that acknowledge the time you spend in and out of the office.
Life @AlloVir
Trust, commitment, and the drive to build something together. Interested in being part of our vision? Check out our open positions.
AlloVir is the global leader in developing VST immunotherapies
We develop highly innovative, allogeneic, off-the-shelf, virus-specific T cell (VST) therapies designed to prevent and treat life-threatening viral diseases.
Our Pipeline
Our allogeneic, off-the-shelf VST therapy candidates target 11 different devastating viruses as treatment or prevention.
AlloVir does not control and is not responsible for the content on the website you are about to visit. AlloVir is providing this link as a convenience, and this link does not imply AlloVir’s endorsement of any material on the website you are about to visit. Do you wish to continue?
AlloVir does not control and is not responsible for the content on the website you are about to visit. AlloVir is providing this link as a convenience, and this link does not imply AlloVir’s endorsement of any material on the website you are about to visit. Do you wish to continue?
